Wenzel Spine commenced U.S. launch of revisions to the VariLift®-C standalone interbody fusion system, including three new heights (8, 9 and 10MM) and minimally invasive instrumentation.
VariLift-C received its initial FDA 510(k) clearance in 2011, and is indicated for skeletally mature patients with cervical degenerative disc disease at one level. It’s placed unilaterally or bilaterally via an anterior approach with autograft bone, with the option of supplemental fixation. The device expands in situ, obviating the need for plates and screws.
In the U.S., Wenzel also markets the VariLift-LX lumbar interbody fusion device for standalone use.
Source: Wenzel Spine, Inc.
Wenzel Spine commenced U.S. launch of revisions to the VariLift®-C standalone interbody fusion system, including three new heights (8, 9 and 10MM) and minimally invasive instrumentation.
VariLift-C received its initial FDA 510(k) clearance in 2011, and is indicated for skeletally mature patients with cervical degenerative disc disease at one...
Wenzel Spine commenced U.S. launch of revisions to the VariLift®-C standalone interbody fusion system, including three new heights (8, 9 and 10MM) and minimally invasive instrumentation.
VariLift-C received its initial FDA 510(k) clearance in 2011, and is indicated for skeletally mature patients with cervical degenerative disc disease at one level. It’s placed unilaterally or bilaterally via an anterior approach with autograft bone, with the option of supplemental fixation. The device expands in situ, obviating the need for plates and screws.
In the U.S., Wenzel also markets the VariLift-LX lumbar interbody fusion device for standalone use.
Source: Wenzel Spine, Inc.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
